Final results of a randomised trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. "Tomudex" Colorectal Cancer Study Group

Ann Oncol. 1996 Nov;7(9):961-5. doi: 10.1093/oxfordjournals.annonc.a010800.

Authors

D Cunningham¹, J R Zalcberg, U Rath, I Oliver, E van Cutsem, C Svensson, J F Seitz, P Harper, D Kerr, G Perez-Manga

Affiliation

¹ CRC Section of Medicine, Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK.

PMID: 9006748
DOI: 10.1093/oxfordjournals.annonc.a010800

No abstract available

Publication types

Clinical Trial
Comparative Study
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Adenocarcinoma / drug therapy*
Adult
Aged
Aged, 80 and over
Antimetabolites, Antineoplastic / therapeutic use*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Colorectal Neoplasms / drug therapy*
Female
Fluorouracil / administration & dosage
Follow-Up Studies
Humans
Leucovorin / administration & dosage
Longitudinal Studies
Male
Middle Aged
Quinazolines / therapeutic use*
Thiophenes / therapeutic use*

Substances

Antimetabolites, Antineoplastic
Quinazolines
Thiophenes
raltitrexed
Leucovorin
Fluorouracil